Inflammatory bowel disease, often called IBD, is a long-term condition that causes inflammation in the digestive system. The ...
There is a critical unmet need to help tighten and maintain a healthy intestinal barrier and treat a leaky gut. Researchers have now found that a unique strain of probiotic bacteria, Bifidobacterium ...
Most people with Crohn’s disease or ulcerative colitis report experiencing some form of stigma, or unfair treatment due to their condition.
Transferrin Receptor Shows Promise as Iron Marker in IBD Soluble transferrin receptor may predict iron deficiency in patients with non anaemic ulcerative colitis; in patients with Crohn's disease, it ...
Biologists converted gut bacteria into miniature protein factories that manufacture and release a sustained flow of targeted proteins inside the lower intestines. This technique solves one of the ...
Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ...
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized ...
The gut microbiome is an important ecosystem of microbes that lives in each one of us, and its strength affects our overall health. However, the small intestine is an underappreciated part of the gut ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results